Literature DB >> 24083842

Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults.

Krishna Rao1, Dejan Micic, Elizabeth Chenoweth, Lili Deng, Andrzej T Galecki, Cathrin Ring, Vincent B Young, David M Aronoff, Preeti N Malani.   

Abstract

OBJECTIVES: To determine the role of impaired functional status as a risk factor for severe Clostridium difficile infection (CDI) in older adults.
DESIGN: Prospective cohort study.
SETTING: University of Michigan Health System, a 930-bed tertiary care hospital. PARTICIPANTS: Hospitalized individuals with CDI aged 50 and older. MEASUREMENTS: Demographic and clinical characteristics and a composite outcome, CDI severity score: fever (>38°C), acute organ dysfunction, white blood cell count greater than 15,000/μL, lack of response to therapy, intensive care unit admission, need for colectomy, or death from CDI. Preadmission functional status was assessed according to ability to perform activities of daily living (ADLs); participants were assigned to an ADL class (independent, some assistance, full assistance). Secondary outcomes included length of stay, 90-day mortality and readmission, and CDI recurrence.
RESULTS: Ninety hospitalized individuals with CDI were identified (mean age 66.6 ± 10.2); 58 (64.4%) had severe CDI as measured according to a positive severity score. At baseline, 25 (27.8%) required assistance with ADLs. On univariate analysis, ADL class of full assistance was associated with a positive severity score (odds ratio (OR) = 7, 95% confidence interval (CI) = 1.83-26.79, P = .004). In a multivariable model including age, ADL class, congestive heart failure, diabetes mellitus, depression, weighted Charlson-Deyo comorbidity score, immunosuppression, prior CDI, and proton pump inhibitor use, an ADL class of full assistance retained its association with a positive severity score (OR = 8.1, 95% CI = 1.24-52.95, P = .03). ADL class was not associated with secondary outcomes.
CONCLUSION: In this cohort of hospitalized older adults, impaired functional status was an independent risk factor for severe CDI.
© 2013, Copyright the Authors Journal compilation © 2013, The American Geriatrics Society.

Entities:  

Keywords:  Clostridium difficile; aging; colitis; geriatric; infection

Mesh:

Year:  2013        PMID: 24083842      PMCID: PMC3801297          DOI: 10.1111/jgs.12442

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  34 in total

Review 1.  Clinical practice. Antibiotic-associated diarrhea.

Authors:  John G Bartlett
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

2.  Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function.

Authors:  Gerly A C Brito; Gail W Sullivan; William P Ciesla; Holliday T Carper; Gerald L Mandell; Richard L Guerrant
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

3.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

4.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

5.  Impaired leucocyte functions in diabetic patients.

Authors:  M Delamaire; D Maugendre; M Moreno; M C Le Goff; H Allannic; B Genetet
Journal:  Diabet Med       Date:  1997-01       Impact factor: 4.359

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Factors associated with prolonged symptoms and severe disease due to Clostridium difficile.

Authors:  L Kyne; C Merry; B O'Connell; A Kelly; C Keane; D O'Neill
Journal:  Age Ageing       Date:  1999-03       Impact factor: 10.668

8.  Clostridium difficile toxin A. Interactions with mucus and early sequential histopathologic effects in rabbit small intestine.

Authors:  A A Lima; D J Innes; K Chadee; D M Lyerly; T D Wilkins; R L Guerrant
Journal:  Lab Invest       Date:  1989-10       Impact factor: 5.662

9.  Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea.

Authors:  Lorraine Kyne; Stavros Sougioultzis; Lynne V McFarland; Ciarán P Kelly
Journal:  Infect Control Hosp Epidemiol       Date:  2002-11       Impact factor: 3.254

10.  Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.

Authors:  G Hecht; A Koutsouris; C Pothoulakis; J T LaMont; J L Madara
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

View more
  22 in total

1.  A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.

Authors:  Jonathan D Crews; Hoonmo L Koo; Zhi-Dong Jiang; Jeffrey R Starke; Herbert L DuPont
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Gender Differences in Non-Toxigenic Clostridium difficile Colonization and Risk of Subsequent C. difficile Infection.

Authors:  Mukil Natarajan; Mary Am Rogers; Jacob Bundy; Dejan Micic; Seth T Walk; Kavitha Santhosh; Krishna Rao; Spencer Winters; Vincent B Young; David M Aronoff
Journal:  Clin Res Infect Dis       Date:  2015-08-03

3.  Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.

Authors:  Krishna Rao; Dejan Micic; Mukil Natarajan; Spencer Winters; Mark J Kiel; Seth T Walk; Kavitha Santhosh; Jill A Mogle; Andrzej T Galecki; William LeBar; Peter D R Higgins; Vincent B Young; David M Aronoff
Journal:  Clin Infect Dis       Date:  2015-03-31       Impact factor: 9.079

4.  Functional and Cognitive Status in Clostridium difficile Infection in the Hospitalized Elderly: a Retrospective Study of Two Sites.

Authors:  Maria-Jose Fernandez-Cotarelo; Stephanie E Nagy-Agren; Mark E Smolkin; Leticia Jimenez-Diez-Canseco; Maria-Teresa Perez-Pomata; Brian V Shenal; Cirle A Warren
Journal:  J Gen Intern Med       Date:  2019-08       Impact factor: 5.128

5.  Editorial commentary: Host-pathogen interactions in Clostridium difficile infection: it takes two to tango.

Authors:  David M Aronoff
Journal:  Clin Infect Dis       Date:  2014-03-05       Impact factor: 9.079

6.  Fecal microbiota therapy: ready for prime time?

Authors:  Krishna Rao; Vincent B Young; David M Aronoff
Journal:  Infect Control Hosp Epidemiol       Date:  2013-12-02       Impact factor: 3.254

7.  Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel.

Authors:  Wasef Na'amnih; Amos Adler; Tamar Miller-Roll; Dani Cohen; Yehuda Carmeli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-07       Impact factor: 3.267

8.  The relationship between patient functional status and environmental contamination by Clostridium difficile: a pilot study.

Authors:  Rebekah Blakney; Unnur Gudnadottir; Simone Warrack; John C O'Horo; Michael Anderson; Ajay Sethi; Michelle Schmitz; Jennifer Wang; Megan Duster; Emma Ide; Nasia Safdar
Journal:  Infection       Date:  2015-04-14       Impact factor: 3.553

9.  Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.

Authors:  David M Faleck; Hojjat Salmasian; E Yoko Furuya; Elaine L Larson; Julian A Abrams; Daniel E Freedberg
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

Review 10.  Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Krishna Rao; Peter D R Higgins
Journal:  Inflamm Bowel Dis       Date:  2016-07       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.